Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis-Reference-Cited by-同舟云学术

Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis

Published:2019-01-01 Issue:1 Volume:24 Page:318-324
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Voskaridou Ersi¹,Ntanasis-Stathopoulos Ioannis²^ORCID,Christoulas Dimitrios³,Sonnleitner Linda⁴,Papaefstathiou Athanasios⁵,Dimopoulou Maria¹,Missbichler Albert⁴,Kanellias Nikolaos²,Repa Konstantina¹,Papatheodorou Athanasios⁶,Peppa Melpomeni⁵,Hawa Gerhard⁴,Terpos Evangelos²

Affiliation:

1. Thalassemia and Sickle Cell Disease Center, “Laiko” General Hospital, Athens, Greece

2. Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

3. Department of Hematology, 251 General Air-Force Hospital, Athens, Greece

4. FIANOSTICS GmbH, Vienna, Austria

5. Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

6. Department of Biomedical Research, 251 General Air-Force Hospital, Athens, Greece

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2019.1570617

Reference37 articles.

1. Bone disease in β thalassemia patients: past, present and future perspectives

2. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major

3. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia

4. Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of multidisciplinary team continuous care model on psychological behavior and quality of life in children with β-thalassemia major;American Journal of Translational Research;2024

2. Mesenchymal Stem Cell and miRNAs in Obesity-Associated Osteoporosis;Comprehensive Hematology and Stem Cell Research;2024

3. Treatment for osteoporosis in people with beta-thalassaemia;Cochrane Database of Systematic Reviews;2023-05-09

4. New Entity—Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement;Diagnostics;2022-08-09

5. The cutoff of ferritin for evaluation of osteoporosis in patients with Thalassemia Major: A cross-sectional analytic study;Iranian Journal of Pediatric Hematology & Oncology;2022-03-30